About us

Athebio at a glance:

Profound Drug Discovery Expertise

Founded in 2019, Athebio brings together a team with a proven track record and extensive expertise in biotherapeutics, specializing in drug discovery and biotherapeutic engineering.

Driven by scientific excellence and innovation

Athebio is a bootstrapped Biotech headquartered in Zürich, Switzerland

Efficient Athebody® Discovery Engine

Athebio has developed the Athebody® platform, which integrates DARPins with a highly efficient discovery engine, unlocking biology across diverse therapeutic areas and applications.

Enabling Drug Developers

Athebio addresses the needs of drug developers by partnering to provide access to its Athebody® DARPin technology, enabling innovative biological solutions across a variety of applications.

Dedicated to Strategic Partnerships

Athebio’s business model centers on strategic partnerships and technology transfer, fostering collaboration and innovation.

Our Team

We are driven by curiosity, creativity, and the passion for innovation. Focused on successful partnership, we strive for excellence in everything we do. We embrace the diversity of our team and are committed to building an inspiring, empowering, and caring environment fostering personal responsibility, development, and growth. As part of nature and society, we act ethically and strive to create a positive impact in the world.